T-CELL AND NEURONAL APOPTOSIS IN HIV INFECTION: IMPLICATIONS FOR THERAPEUTIC INTERVENTION

The pathogenesis of HIV infection involves the selective loss of CD4 + T cells contributing to immune deficiency. Although loss of T cells leading to immune dysfunction in HIV infection is mediated in part by viral infection, there is a much larger effect on noninfected T cells undergoing apoptosis in response to activation stimuli. In the subset of patients with HIV dementia complex, neuronal injury, loss, and apoptosis are observed. Viral proteins, gp120 and Tat, exhibit proapoptotic activities when applied to T cell and neuronal cultures by direct and indirect mechanisms. The pathways leading to cell death involve the activation of one or more death receptor pathways (i.e., TNF-α, Fas, and TRAIL receptors), chemokine receptor signaling, cytokine dysregulation, caspase activation, calcium mobilization, and loss of mitochondrial membrane potential. In this review, the mechanisms involved in T-cell and neuronal apoptosis, as well as antiapoptotic pathways potentially amenable to therapeutic application, are discussed.

[1]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[2]  Neuroimmunomodulation , 2004 .

[3]  Chaohong Sun,et al.  Regulation of the Apaf-1/Caspase-9 Apoptosome by Caspase-3 and XIAP* , 2003, The Journal of Biological Chemistry.

[4]  Glen S. Hatfield,et al.  Tat-Neutralizing Antibodies in Vaccinated Macaques , 2003, Journal of Virology.

[5]  J. Altman,et al.  IL-15 enhances survival and function of HIV-specific CD8+ T cells. , 2003, Blood.

[6]  C. Belka,et al.  The tyrosine kinase Lck is involved in regulation of mitochondrial apoptosis pathways , 2003, Oncogene.

[7]  D. Watkins,et al.  Prevention of Disease Induced by a Partially Heterologous AIDS Virus in Rhesus Monkeys by Using an Adjuvanted Multicomponent Protein Vaccine , 2003, Journal of Virology.

[8]  K. Khalili,et al.  Neuroprotective effects of IGF-I against TNFalpha-induced neuronal damage in HIV-associated dementia. , 2003, Virology.

[9]  Qiang Zhou,et al.  HIV‐1 Tat targets microtubules to induce apoptosis, a process promoted by the pro‐apoptotic Bcl‐2 relative Bim , 2002, The EMBO journal.

[10]  A. Nath Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. , 2002, The Journal of infectious diseases.

[11]  R. O'Connor,et al.  Insulin‐like growth factor‐1 activates Akt and Jun N‐terminal kinases (JNKs) in promoting the survival of T lymphocytes , 2002, Immunology.

[12]  P. Mulholland,et al.  Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-d-aspartate receptor , 2002, Brain Research.

[13]  D. Montefiori,et al.  Vaccination of Macaques with Long-Standing SIVmac251 Infection Lowers the Viral Set Point After Cessation of Antiretroviral Therapy1 , 2002, The Journal of Immunology.

[14]  M. Mattson,et al.  Calcium Dysregulation and Neuronal Apoptosis by the HIV‐1 Proteins Tat and gp120 , 2002, Journal of acquired immune deficiency syndromes.

[15]  Mark G. Lewis,et al.  Immunogenicity of HIV-1 IIIB and SHIV 89.6P Tat and Tat toxoids in rhesus macaques: induction of humoral and cellular immune responses. , 2002, DNA and cell biology.

[16]  D. Montefiori,et al.  Crosslinked HIV-1 envelope–CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C. Payá,et al.  CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells , 2002, AIDS.

[18]  D. Weiner,et al.  Adenovirus encoding HIV-1 Vpr activates caspase 9 and induces apoptotic cell death in both p53 positive and negative human tumor cell lines , 2002, Oncogene.

[19]  M. Lederman,et al.  Short Communication: Effect of Etanercept (Enbrel) on Interleukin 6, Tumor Necrosis Factor α, and Markers of Immune Activation in HIV-Infected Subjects Receiving Interleukin 2 , 2002 .

[20]  J. Cambier,et al.  Ligation of human CD4 interferes with antigen-induced activation of primary T cells. , 2002, Immunology letters.

[21]  Yili Yang,et al.  HIV Tat Binds Egr Proteins and Enhances Egr-dependent Transactivation of the Fas Ligand Promoter* , 2002, The Journal of Biological Chemistry.

[22]  Junying Yuan,et al.  Caspase Cascades in Human Immunodeficiency Virus-Associated Neurodegeneration , 2002, The Journal of Neuroscience.

[23]  J. Southgate,et al.  Effects of insulin-like growth factors I and II on tumour-necrosis-factor-alpha-induced apoptosis in early murine embryos. , 2002, Reproduction, fertility, and development.

[24]  Mark G. Lewis,et al.  Outcome of Simian-Human Immunodeficiency Virus Strain 89.6p Challenge following Vaccination of Rhesus Macaques with Human Immunodeficiency Virus Tat Protein , 2002, Journal of Virology.

[25]  Todd M. Allen,et al.  Tat-Vaccinated Macaques Do Not Control Simian Immunodeficiency Virus SIVmac239 Replication , 2002, Journal of Virology.

[26]  M. Mudryj,et al.  Simian Immunodeficiency Virus Nef Protein Delays the Progression of CD4+ T Cells through G1/S Phase of the Cell Cycle , 2002, Journal of Virology.

[27]  J. Mills,et al.  Human Immunodeficiency Virus Type 1 Nef Binds to Tumor Suppressor p53 and Protects Cells against p53-Mediated Apoptosis , 2002, Journal of Virology.

[28]  C. Rapp,et al.  Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1)- and TNFR2-mediated apoptosis in HIV infection: relation to expression of Bcl-2 and active caspase-8 and caspase-3. , 2002, Blood.

[29]  J. Corbeil,et al.  Productive HIV-1 Infection of Primary CD4+ T Cells Induces Mitochondrial Membrane Permeabilization Leading to a Caspase-independent Cell Death* , 2002, The Journal of Biological Chemistry.

[30]  A. Giordano,et al.  Functional interaction between cyclin T1/cdk9 and Purα determines the level of TNFα promoter activation by Tat in glial cells , 2001, Journal of Neuroimmunology.

[31]  J. Altman,et al.  Increased CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells. , 2001, Immunity.

[32]  Stephan Bour,et al.  The Human Immunodeficiency Virus Type 1 Accessory Protein Vpu Induces Apoptosis by Suppressing the Nuclear Factor κB–dependent Expression of Antiapoptotic Factors , 2001, The Journal of experimental medicine.

[33]  A. Schürmann,et al.  HIV-1 Nef associated PAK and PI3-Kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals , 2001, Nature Medicine.

[34]  Xavier Alvarez,et al.  Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system , 2001, Glia.

[35]  D. Noonan,et al.  HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. , 2001, Biochemical and biophysical research communications.

[36]  C. Hallahan,et al.  CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients , 2001, AIDS.

[37]  C. Petito,et al.  Detection of HIV‐1 Gene Sequences in Hippocampal Neurons Isolated from Postmortem AIDS Brains by Laser Capture Microdissection , 2001, Journal of neuropathology and experimental neurology.

[38]  S. Dewhurst,et al.  Neurotrophins prevent HIV Tat‐induced neuronal apoptosis via a nuclear factor‐κB (NF‐κB)‐dependent mechanism , 2001 .

[39]  V. Robert-Hebmann,et al.  Binding of Human Immunodeficiency Virus Type 1 gp120 to CXCR4 Induces Mitochondrial Transmembrane Depolarization and Cytochromec-Mediated Apoptosis Independently of Fas Signaling , 2001, Journal of Virology.

[40]  J. Brady,et al.  HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells. , 2001, AIDS research and human retroviruses.

[41]  M. Mattson,et al.  HIV‐1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity , 2001, Journal of neurochemistry.

[42]  N. Selliah,et al.  HIV-1 NL4-3, but not IIIB, inhibits JAK3/STAT5 activation in CD4(+) T cells. , 2001, Virology.

[43]  C. Lang,et al.  Tissue-specific regulation of IGF-I and IGF-binding proteins in response to TNFα , 2001 .

[44]  J. Tschopp,et al.  NF-κB Signals Induce the Expression of c-FLIP , 2001, Molecular and Cellular Biology.

[45]  M. Kitamura,et al.  Expression, regulation, and function of inhibitor of apoptosis family genes in rat mesangial cells. , 2001, Kidney international.

[46]  Y. Gu,et al.  HIV Tat activates c-Jun amino-terminal kinase through an oxidant-dependent mechanism. , 2001, Virology.

[47]  F. Peruzzi,et al.  Anti-apoptotic Signaling of the Insulin-like Growth Factor-I Receptor through Mitochondrial Translocation of c-Raf and Nedd4* , 2001, The Journal of Biological Chemistry.

[48]  L. Glimcher,et al.  Tumor Necrosis Factor Receptor–Associated Factor (Traf)2 Represses the T Helper Cell Type 2 Response through Interaction with Nfat-Interacting Protein (Nip45) , 2001, The Journal of experimental medicine.

[49]  Simon C Watkins,et al.  Overexpression of tumor necrosis factor- alpha activates both anti- and pro-apoptotic pathways in the myocardium. , 2001, Journal of molecular and cellular cardiology.

[50]  S. Croul,et al.  Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas , 2001, Oncogene.

[51]  R. Compans,et al.  HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis. , 2001, Virology.

[52]  P. Krammer,et al.  The effect of HIV‐1 regulatory proteins on cellular genes: derepression of the IL‐2 promoter by Tat , 2001, European journal of immunology.

[53]  S. Wesselingh,et al.  Correlation between neurological progression and astrocyte apoptosis in HIV‐associated dementia , 2001, Annals of neurology.

[54]  I. Hewlett,et al.  Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: upregulation of trail in primary human macrophages by HIV-1 tat. , 2001, Journal of biomedical science.

[55]  Stuart A. Lipton,et al.  Pathways to neuronal injury and apoptosis in HIV-associated dementia , 2001, Nature.

[56]  A. Lackner,et al.  Perivascular Macrophages Are the Primary Cell Type Productively Infected by Simian Immunodeficiency Virus in the Brains of Macaques , 2001, The Journal of experimental medicine.

[57]  W. Greene,et al.  HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell , 2001, Nature.

[58]  E. Masliah,et al.  Amelioration of Neurotoxic Effects of HIV Envelope Protein gp120 by Fibroblast Growth Factor: A Strategy for Neuroprotection , 2001, Journal of neuropathology and experimental neurology.

[59]  S. Rowland-Jones,et al.  Skewed maturation of memory HIV-specific CD8 T lymphocytes , 2001, Nature.

[60]  R. Locksley,et al.  The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.

[61]  F. Kashanchi,et al.  Cell Cycle Regulation of Human Interleukin-8 Gene Expression by the Human Immunodeficiency Virus Type 1 Tat Protein , 2001, Journal of Virology.

[62]  R. Mitsuyasu The potential role of interleukin-2 in HIV , 2001, AIDS.

[63]  Sunyoung Kim,et al.  Brief Comment: Stable Expression of Human Immunodeficiency Virus Type 1 Nef Confers Resistance against Fas-Mediated Apoptosis , 2001 .

[64]  C. Payá,et al.  Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes. , 2001, The Journal of clinical investigation.

[65]  G. Shulman,et al.  Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. , 2001, The Journal of clinical investigation.

[66]  J. Groopman,et al.  HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes. , 2001, Blood.

[67]  G. Robichaud,et al.  HIV type 1 nef gene inhibits tumor necrosis factor alpha-induced apoptosis and promotes cell proliferation through the action of MAPK and JNK in human glial cells. , 2000, AIDS research and human retroviruses.

[68]  W. Fiers,et al.  Structure/Function Analysis of p55 Tumor Necrosis Factor Receptor and Fas-associated Death Domain , 2000, The Journal of Biological Chemistry.

[69]  R. Tanzi,et al.  Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands , 2000, Nature Medicine.

[70]  M. Benkirane,et al.  Tat Protein of Human Immunodeficiency Virus Type 1 Induces Interleukin-10 in Human Peripheral Blood Monocytes: Implication of Protein Kinase C-Dependent Pathway , 2000, Journal of Virology.

[71]  H. Xiao,et al.  Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[72]  A. Bansal,et al.  Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum , 2000, Brain Research.

[73]  W. Marasco,et al.  Grb3-3 Is Up-regulated in HIV-1-infected T-cells and Can Potentiate Cell Activation through NFATc* , 2000, The Journal of Biological Chemistry.

[74]  O. Kutsch,et al.  Induction of the Chemokines Interleukin-8 and IP-10 by Human Immunodeficiency Virus Type 1 Tat in Astrocytes , 2000, Journal of Virology.

[75]  W. Marasco,et al.  Upregulation of the apoptosis-associated protein Grb3-3 in HIV-1-infected human CD4(+) lymphocytes. , 2000, Biochemical and biophysical research communications.

[76]  R. Testi,et al.  Primary macrophages infected by human immunodeficiency virus trigger CD95‐mediated apoptosis of uninfected astrocytes , 2000, Journal of leukocyte biology.

[77]  Y. Lau,et al.  Insulin-Like Growth Factor 1 Promotes Cord Blood T Cell Maturation and Inhibits Its Spontaneous and Phytohemagglutinin-Induced Apoptosis Through Different Mechanisms1 , 2000, The Journal of Immunology.

[78]  Avindra Nath,et al.  Release of Calcium from Inositol 1,4,5-Trisphosphate Receptor-Regulated Stores by HIV-1 Tat Regulates TNF-α Production in Human Macrophages1 , 2000, The Journal of Immunology.

[79]  S. Manna,et al.  Differential Requirement for p56lck in HIV-tat Versus TNF-Induced Cellular Responses: Effects on NF-κB, Activator Protein-1, c-Jun N-Terminal Kinase, and Apoptosis1 , 2000, The Journal of Immunology.

[80]  D. Noonan,et al.  Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat. , 2000, Biochemical and biophysical research communications.

[81]  R. O'Connor,et al.  The insulin‐like growth factor‐I receptor is regulated by CD28 and protects activated T cells from apoptosis , 2000, European journal of immunology.

[82]  A. Burny,et al.  Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques , 2000 .

[83]  E. Masliah,et al.  Fibroblast growth factor modulates HIV coreceptor CXCR4 expression by neural cells , 2000 .

[84]  P. Krammer,et al.  T cell activation‐induced and HIV Tat‐enhanced CD95(APO‐1 / Fas) ligand transcription involves NF‐κB , 2000 .

[85]  Melina V Jones,et al.  Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: Protection by memantine , 2000, Annals of neurology.

[86]  S. Gartner HIV Infection and Dementia , 2000, Science.

[87]  R. Cooney,et al.  Tat mediates apoptosis in vivo in the rat central nervous system. , 2000, Biochemical and biophysical research communications.

[88]  M. Mattson,et al.  Activity‐Dependent Neurotrophic Factor Peptide (ADNF9) Protects Neurons Against Oxidative Stress‐Induced Death , 1999, Journal of neurochemistry.

[89]  A. Nath,et al.  Involvement of Inositol 1,4,5‐Trisphosphate‐Regulated Stores of Intracellular Calcium in Calcium Dysregulation and Neuron Cell Death Caused by HIV‐1 Protein Tat , 1999, Journal of neurochemistry.

[90]  M. Giacca,et al.  Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells. , 1999, AIDS.

[91]  G. Barillari,et al.  The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor. , 1999, Blood.

[92]  M. Mattson,et al.  Evidence that Par-4 participates in the pathogenesis of HIV encephalitis. , 1999, The American journal of pathology.

[93]  E. Major,et al.  Transient Exposure to HIV-1 Tat Protein Results in Cytokine Production in Macrophages and Astrocytes , 1999, The Journal of Biological Chemistry.

[94]  J. Heeney,et al.  Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine , 1999, Nature Medicine.

[95]  G. Jansen,et al.  Overexpression of nerve growth factor and basic fibroblast growth factor in AIDS dementia complex , 1999, Journal of Neuroimmunology.

[96]  Chrétien,et al.  Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage , 1999, Neuropathology and applied neurobiology.

[97]  S. Croul,et al.  Molecular pathway involved in HIV‐1‐induced CNS pathology: role of viral regulatory protein, Tat , 1999, Journal of leukocyte biology.

[98]  S. Bartz,et al.  Human Immunodeficiency Virus Type 1 Tat Induces Apoptosis and Increases Sensitivity to Apoptotic Signals by Up-Regulating FLICE/Caspase-8 , 1999, Journal of Virology.

[99]  D. Olive,et al.  Human Immunodeficiency Virus Type 1 Nef Protein Sensitizes CD4+ T Lymphoid Cells to Apoptosis via Functional Upregulation of the CD95/CD95 Ligand Pathway , 1999 .

[100]  R. Osathanondh,et al.  Apoptosis Induced by Infection of Primary Brain Cultures with Diverse Human Immunodeficiency Virus Type 1 Isolates: Evidence for a Role of the Envelope , 1999, Journal of Virology.

[101]  M. Mattson,et al.  Pivotal Role of Mitochondrial Calcium Uptake in Neural Cell Apoptosis and Necrosis , 1999, Journal of neurochemistry.

[102]  F. Silverstein,et al.  Tat, a human immunodeficiency virus-1 derived protein, augments excitotoxic hippocampal injury in neonatal rats , 1999, Neuroscience.

[103]  Carolyn R. Casella,et al.  Vpu Increases Susceptibility of Human Immunodeficiency Virus Type 1-Infected Cells to Fas Killing , 1999, Journal of Virology.

[104]  G. Haegeman,et al.  Activation of p42/p44 mitogen‐activated protein kinases (MAPK) and p38 MAPK by tumor necrosis factor (TNF) is mediated through the death domain of the 55‐kDa TNF receptor , 1998, FEBS letters.

[105]  M. Mattson,et al.  HIV-1 Protein Tat Induces Apoptosis of Hippocampal Neurons by a Mechanism Involving Caspase Activation, Calcium Overload, and Oxidative Stress , 1998, Experimental Neurology.

[106]  A. Rice,et al.  Tat-Associated Kinase, TAK, Activity Is Regulated by Distinct Mechanisms in Peripheral Blood Lymphocytes and Promonocytic Cell Lines , 1998, Journal of Virology.

[107]  K. Khalili,et al.  Structure and function of HIV-1 and SIV Tat proteins based on carboxy-terminal truncations, chimeric Tat constructs, and NMR modeling. , 1998, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[108]  John Calvin Reed,et al.  Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.

[109]  Irene Bosch,et al.  Tat Protein Induces Human Immunodeficiency Virus Type 1 (HIV-1) Coreceptors and Promotes Infection with both Macrophage-Tropic and T-Lymphotropic HIV-1 Strains , 1998, Journal of Virology.

[110]  Guoji Wang,et al.  Expression of brain‐derived neurotrophic factor protein in activated microglia of human immunodeficiency virus type 1 encephalitis , 1998, Neuropathology and applied neurobiology.

[111]  R. Rabin,et al.  HIV-1 Tat protein mimicry of chemokines. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[112]  G. Natoli,et al.  Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling. , 1998, Biochemical pharmacology.

[113]  R. Bailey,et al.  Insulin-like growth factor-I resistance. , 1998, Endocrine reviews.

[114]  B. Peterlin,et al.  The Ability of Positive Transcription Elongation Factor b To Transactivate Human Immunodeficiency Virus Transcription Depends on a Functional Kinase Domain, Cyclin T1, and Tat , 1998, Journal of Virology.

[115]  J. Kyriakis,et al.  Tumor Necrosis Factor Signaling to Stress-activated Protein Kinase (SAPK)/Jun NH2-terminal Kinase (JNK) and p38 , 1998, The Journal of Biological Chemistry.

[116]  A. Nath,et al.  HIV-1 Tat Molecular Diversity and Induction of TNF-α: Implications for HIV-Induced Neurological Disease , 1998, Neuroimmunomodulation.

[117]  S. Manna,et al.  HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1. , 1998, Journal of immunology.

[118]  L. Epstein,et al.  HIV-1 Tat Induces Neuronal Death via Tumor Necrosis Factor-α and Activation of Non-N-methyl-d-aspartate Receptors by a NFκB-Independent Mechanism* , 1998, The Journal of Biological Chemistry.

[119]  J. Brady,et al.  Regulation of TNFα and TGFβ-1 gene transcription by HIV-1 Tat in CNS cells , 1998, Journal of Neuroimmunology.

[120]  R. Zidovetzki,et al.  Human immunodeficiency virus Tat protein induces interleukin 6 mRNA expression in human brain endothelial cells via protein kinase C- and cAMP-dependent protein kinase pathways. , 1998, AIDS research and human retroviruses.

[121]  C. Payá,et al.  The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection. , 1998, The Journal of clinical investigation.

[122]  W. Blattner,et al.  Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. , 1998, Journal of human virology.

[123]  E. Major,et al.  Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[124]  A. Lazzarin,et al.  Cerebrospinal fluid HIV‐1 RNA levels: correlation with HIV encephalitis , 1998, AIDS.

[125]  Ping Wei,et al.  A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.

[126]  C. Tacchetti,et al.  Monocyte‐derived dendritic cells and monocytes migrate to HIV‐Tat RGD and basic peptides , 1998, AIDS.

[127]  M. Mattson,et al.  Calcium and reactive oxygen species mediate staurosporine‐induced mitochondrial dysfunction and apoptosis in PC12 cells , 1998, Journal of neuroscience research.

[128]  T. Jernigan,et al.  Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. , 1998, Archives of neurology.

[129]  A. Nath,et al.  Neurobiological aspects of human immunodeficiency virus infection:Neurotoxic mechanisms , 1998, Progress in Neurobiology.

[130]  S. Korsmeyer,et al.  A major human immunodeficiency virus type 1-initiated killing pathway distinct from apoptosis , 1997, Journal of virology.

[131]  J. McArthur,et al.  Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain , 1997, Annals of neurology.

[132]  J. Torres-Roca,et al.  Interleukin-1β Converting Enzyme–like Protease Involvement in Fas-induced and Activation-induced Peripheral Blood T Cell Apoptosis in HIV Infection. TNF-related Apoptosis-inducing Ligand Can Mediate Activation-induced T Cell Death in HIV Infection , 1997, The Journal of experimental medicine.

[133]  D. Hazuda,et al.  P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. , 1997, Genes & development.

[134]  M. Mathews,et al.  Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. , 1997, Genes & development.

[135]  Luigi Buonaguro,et al.  HIV‐1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix‐associated heparan sulfate proteoglycans through its basic region , 1997, AIDS.

[136]  S. Hochman,et al.  Neuronal excitatory properties of human immunodeficiency virus type 1 tat protein , 1997, Neuroscience.

[137]  A. Nath,et al.  The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. , 1997, The Journal of biological chemistry.

[138]  J. Meldolesi,et al.  HIV‐1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid , 1997, FEBS letters.

[139]  C. Ambrosino,et al.  HIV-1 Tat Induces the Expression of the Interleukin-6 (IL6) Gene by Binding to the IL6 Leader RNA and by Interacting with CAAT Enhancer-binding Protein β (NF-IL6) Transcription Factors* , 1997, The Journal of Biological Chemistry.

[140]  M. McGrath,et al.  Unique monocyte subset in patients with AIDS dementia , 1997, The Lancet.

[141]  Y. Adachi,et al.  Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cells apoptosis: a possible mechanism of bystander cell death in HIV infection. , 1997, Journal of immunology.

[142]  N. Young,et al.  Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication. , 1997, Blood.

[143]  H. Wiśniewski,et al.  Microencephaly in children congenitally infected with human immunodeficiency virus – a gross-anatomical morphometric study , 1997, Acta Neuropathologica.

[144]  E. Verdin,et al.  Dual role of HIV Tat in regulation of apoptosis in T cells. , 1997, Journal of immunology.

[145]  M. Colombo,et al.  Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4+ T-cell clones with different T-helper phenotypes: role of CD95/CD95L interactions. , 1997, Blood.

[146]  J. Xiang,et al.  BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[147]  Elizabeth Yang,et al.  Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.

[148]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[149]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[150]  S. Lipton Similarity of Neuronal Cell Injury and Death in AIDS Dementia and Focal Cerebral Ischemia: Potential Treatment with NMDA Open‐Channel Blockers and Nitric Oxide‐Related Species , 1996, Brain pathology.

[151]  I. Herr,et al.  Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis , 1996, Journal of virology.

[152]  C. Smith,et al.  Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals. , 1996, International immunology.

[153]  O. Meucci,et al.  gp120-Induced Neurotoxicity in Hippocampal Pyramidal Neuron Cultures: Protective Action of TGF-β1 , 1996, The Journal of Neuroscience.

[154]  M. Giacca,et al.  Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1 , 1996, Journal of virology.

[155]  S. Nagata,et al.  Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. , 1996, Blood.

[156]  K. Khalili,et al.  Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[157]  G. Nuovo,et al.  AIDS Dementia Is Associated with Massive, Activated HIV-1 Infection and Concomitant Expression of Several Cytokines , 1996, Molecular medicine.

[158]  D. Tenen,et al.  CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter , 1996, Molecular and cellular biology.

[159]  D. Magnuson,et al.  Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic , 1996, Journal of virology.

[160]  E. Major,et al.  Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes , 1996, Journal of virology.

[161]  B. Spiegelman,et al.  IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.

[162]  D. Fuchs,et al.  Oxidative Stress and Apoptosis in HIV Infection , 1996, Science.

[163]  Y. Ben-Ari,et al.  The HIV‐1 envelope protein GP120 induces neuronal apoptosis in hippocampal slices , 1996, Neuroreport.

[164]  L. Mucke,et al.  Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine , 1996, Brain Research.

[165]  C. Payá,et al.  Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes , 1996, Journal of virology.

[166]  S. Lipton,et al.  The Coat Protein gp120 of HIV‐1 Inhibits Astrocyte Uptake of Excitatory Amino Acids via Macrophage Arachidonic Acid , 1995, The European journal of neuroscience.

[167]  J. Glass,et al.  Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia , 1995, Annals of neurology.

[168]  G D Pearlson,et al.  Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. , 1995, The American journal of psychiatry.

[169]  M. Krönke,et al.  TNF-induced activation of NF-kappa B. , 1995, Immunobiology.

[170]  S. Rowland-Jones,et al.  Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[171]  P. Krammer,et al.  Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120 , 1995, Nature.

[172]  G. Nisticó,et al.  HIV-1 gp120 produces DNA fragmentation in the cerebral cortex of rat. , 1995, Biochemical and biophysical research communications.

[173]  L. Epstein,et al.  Apoptotic neurons in brains from paediatric patients with HIV‐I encephalitis and progressive encephalopathy , 1995, Neuropathology and applied neurobiology.

[174]  Christine A. Lee,et al.  Presence of CD3+CD8+Bcl-2(low) lymphocytes undergoing apoptosis and activated macrophages in lymph nodes of HIV-1+ patients. , 1995, The American journal of pathology.

[175]  L. Herzenberg,et al.  Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals , 1995, The Journal of experimental medicine.

[176]  Y. Lévy,et al.  Neuronal apoptosis in HIV infection in adults , 1995, Neuropathology and applied neurobiology.

[177]  A. Fauci,et al.  Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. , 1995, Journal of immunology.

[178]  V. Metelev,et al.  Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. , 1995, Science.

[179]  M E Greenberg,et al.  Calcium signaling in neurons: molecular mechanisms and cellular consequences. , 1995, Science.

[180]  Howard E. Gendelman,et al.  Dementia Associated with the Acquired Immunodeficiency Syndrome , 1995 .

[181]  G. Pavlakis,et al.  Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function , 1995, Journal of virology.

[182]  R. Brownstone,et al.  Human immunodeficiency virus type 1 tat activates non—N‐methyl‐D‐aspartate excitatory amino acid receptors and causes neurotoxicity , 1995, Annals of neurology.

[183]  T. Curiel,et al.  Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes , 1995, Nature Medicine.

[184]  G. Arbuthnott,et al.  The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines. , 1994, Virology.

[185]  M. Dohadwala,et al.  Exogenous tat protein activates central nervous system-derived endothelial cells , 1994, Journal of Neuroimmunology.

[186]  B. Tavolato,et al.  Cerebrospinal fluid analysis in HIV‐1‐infected children: immunological and virological findings before and after AZT therapy , 1994, Acta paediatrica.

[187]  F. Barré-Sinoussi,et al.  Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[188]  M. Baer,et al.  C/EBP-related protein 2 confers lipopolysaccharide-inducible expression of interleukin 6 and monocyte chemoattractant protein 1 to a lymphoblastic cell line. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[189]  L. Mucke,et al.  Central nervous system damage produced by expression of the HIV-1 coat protein gpl20 in transgenic mice , 1994, Nature.

[190]  S. D’Mello,et al.  Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[191]  J. Becker,et al.  Dementia in AIDS patients , 1993, Neurology.

[192]  O. Selnes,et al.  Clinical‐neuropathologic correlation in HIV‐associated dementia , 1993, Neurology.

[193]  S. Capitani,et al.  Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. , 1993, Cancer research.

[194]  G. D. Pearlson,et al.  Reduced basal ganglia volume in HIV‐1‐associated dementia , 1993, Neurology.

[195]  K. Khalili,et al.  Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS. , 1993, Oncogene.

[196]  C. Debouck,et al.  HIV-1 Tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures: RGD sequence dependence. , 1993, AIDS research and human retroviruses.

[197]  J. Glass,et al.  Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dememtia , 1993, Annals of neurology.

[198]  J. Heeney,et al.  Programmed cell death in AIDS-related HIV and SIV infections. , 1993, AIDS research and human retroviruses.

[199]  S. Snyder,et al.  Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[200]  E. Ruoslahti,et al.  A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin , 1993, The Journal of cell biology.

[201]  D. Giulian,et al.  The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[202]  H. Kleinman,et al.  Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein. , 1993, The Journal of biological chemistry.

[203]  S. Lipton Human immunodefciency virus‐infected macrophages, gp120, and N‐methyl‐D‐ aspartate receptor‐mediated new‐otoxicity , 1993 .

[204]  P. Wingfield,et al.  Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation , 1993, Journal of virology.

[205]  G. Zauli,et al.  tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. , 1992, Blood.

[206]  O. Bagasra,et al.  TAR-independent replication of human immunodeficiency virus type 1 in glial cells , 1992, Journal of virology.

[207]  M. Tsang,et al.  Effects of transforming growth factor-beta on murine astrocyte glutamine synthetase activity. Implications in neuronal injury. , 1992, The Journal of clinical investigation.

[208]  F. Miedema,et al.  Programmed death of T cells in HIV-1 infection. , 1992, Science.

[209]  P. Carrieri,et al.  Cerebrospinal fluid cytokines in AIDS dementia complex , 1992, Journal of Neurology.

[210]  J. Bormann,et al.  gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. , 1992, European journal of pharmacology.

[211]  L. Montagnier,et al.  Human immunodeficiency virus type 1–infected monocytic cells can destroy human neural cells after cell‐to‐cell adhesion , 1992, Annals of neurology.

[212]  J. Glass,et al.  Cytokine expression in the brain during the acquired immunodeficiency syndrome , 1992, Annals of neurology.

[213]  A. Capron,et al.  Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals , 1992, The Journal of experimental medicine.

[214]  P. Gluckman,et al.  A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. , 1992, Biochemical and biophysical research communications.

[215]  S. Akira,et al.  Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. , 1992, Blood.

[216]  J. Merrill,et al.  HIV‐1, macrophages, glial cells, and cytokines in AIDS nervous system disease , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[217]  B. Tavolato,et al.  Immunological Markers in the Cerebrospinal Fluid of HIV‐1‐Infected Children , 1991, Acta paediatrica Scandinavica.

[218]  E. Masliah,et al.  Neocortical damage during HIV infection , 1991, Annals of neurology.

[219]  E. Vivés,et al.  Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1 , 1991 .

[220]  D. Giulian,et al.  Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1 , 1990, Science.

[221]  F. Chiodi,et al.  Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system. , 1990, Clinical immunology and immunopathology.

[222]  K. Butler,et al.  Growth and neuroendocrine dysfunction in children with acquired immunodeficiency syndrome. , 1990, The Journal of pediatrics.

[223]  C. Debouck,et al.  Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat , 1990, The Journal of cell biology.

[224]  S. Salahuddin,et al.  Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients , 1990, Nature.

[225]  M. Katze,et al.  Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. , 1990, Science.

[226]  A. Fauci,et al.  Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[227]  K. Frei,et al.  Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid , 1989, Journal of Neuroimmunology.

[228]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[229]  S. Orrenius,et al.  Calcium-activated DNA fragmentation in rat liver nuclei. , 1989, The Journal of biological chemistry.

[230]  G. Nabel,et al.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[231]  Carl O. Pabo,et al.  Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.

[232]  M. Hirsch,et al.  Neurologic manifestations of infection with human immunodeficiency virus. Clinical features and pathogenesis. , 1987, Annals of internal medicine.

[233]  H. Budka,et al.  Brain pathology induced by infection with the human immunodeficiency virus (HIV) , 1987, Acta Neuropathologica.

[234]  B. Navia,et al.  The AIDS dementia complex: II. Neuropathology , 1986, Annals of neurology.

[235]  R. Kapila,et al.  Neuropathologic observations in acquired immunodeficiency syndrome (AIDS) , 1985, Acta Neuropathologica.

[236]  C. Petito,et al.  Subacute encephalitis in acquired immune deficiency syndrome: a postmortem study. , 1984, American journal of clinical pathology.

[237]  J. Cohen,et al.  Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. , 1984, Journal of immunology.

[238]  Manjit,et al.  Neurology , 1912, NeuroImage.

[239]  L. Wilkinson Immunity , 1891, The Lancet.

[240]  Neil Genzlinger A. and Q , 2006 .

[241]  H. Budka,et al.  Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study , 2004, Acta Neuropathologica.

[242]  P. Katsikis,et al.  IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells. , 2003, International immunology.

[243]  K. Khalili,et al.  Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[244]  J. Kim,et al.  HIV-1 viral protein R compromises cellular immune function in vivo. , 2002, International immunology.

[245]  W. Blattner,et al.  Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments. , 2002, Journal of human virology.

[246]  U. Dianzani,et al.  Decreased function of Fas in patients displaying delayed progression of HIV-induced immune deficiency. , 2001, The hematology journal : the official journal of the European Haematology Association.

[247]  C. Decarli,et al.  Cerebrospinal fluid viral load is related to cortical atrophy and not to intracerebral calcifications in children with symptomatic HIV disease. , 2000, Journal of neurovirology.

[248]  B. Peterlin,et al.  Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. , 2000, Immunity.

[249]  S. Lipton Neuronal injury associated with HIV-1: approaches to treatment. , 1998, Annual review of pharmacology and toxicology.

[250]  J. Busciglio,et al.  Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. , 1998, Journal of neurovirology.

[251]  L. Epstein,et al.  Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. , 1997, Journal of neurovirology.

[252]  A. Nath,et al.  Molecular Determinants for Cellular Uptake of Tat Protein of Human Immunodeficiency Virus Type 1 in Brain Cells , 1996 .

[253]  S. Perry,et al.  Tumor Necrosis Factor (cid:97) Inhibits Glutamate Uptake by Primary Human Astrocytes FOR PATHOGENESIS OF HIV-1 , 2022 .

[254]  H. Ushijima,et al.  Neurotoxicity in rat cortical cells caused by N-methyl-D-aspartate (NMDA) and gp120 of HIV-1: induction and pharmacological intervention. , 1996, Progress in molecular and subcellular biology.

[255]  C. Petito,et al.  Evidence of apoptotic cell death in HIV encephalitis. , 1995, The American journal of pathology.

[256]  H. Gendelman,et al.  An experimental model system for HIV-1-induced brain injury. , 1994, Advances in neuroimmunology.

[257]  D. Diloreto,et al.  Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. , 1993, Developmental neuroscience.

[258]  V. Georgiev Virology , 1955, Nature.